Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
The MILO Study (MEK Inhibitor in Low-Grade Serous Ovarian Cancer): A Multi-National, Randomized, Open-Label Phase III Study of MEK162 vs. Physician’s Choice Chemotherapy in Patients with Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.
Open to Accrual
Defintions of terms and FAQ about clinical trials.
Annie Yessaian, M.D.
Other Trial Staff:
Kristy Watkins, R.N., Grace Facio, R.N., Yanli Wang, D.M.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.